Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial

  • S. K. Alalaf, A. K. Jawad, R. K. Jawad, M. S. Ali, N. G. Al Tawil
  • Journal of Thrombosis and Haemostasis, October 2015, Wiley
  • DOI: 10.1111/jth.13164

Bemiparin as a thromboprophylaxis after gynaecological surgeries

What is it about?

Bemiparin is a second generation low molecular heparin which differ from the first generation low molecular weight heparin regarding the mode of action . It was an effective thromboprophylactic drug after it use following benign gynecological surgeries

Why is it important?

This clinical trial is regarded the first to be conducted after benign gynecological surgeries and with a large sample size


Professor Shahla kreem Alalaf
Hawler Medical University

The use of this simple injection following gynecolgical surgeries for women whome were risky to develope VTE resulted in hundered petcent protection against venous thromboembolism event and in our hospital it helped to develop a local guideline fir the use of thromboprophylaxis after gynecological surgeties and it also helped the gynecologists to become familial with its use

Read Publication

The following have contributed to this page: Professor Shahla kreem Alalaf